Vascular Architects

company

About

Vascular Architects are develops and markets devices to treat vascular disease and nonvascular obstructions.

  • 51 - 100

Details

Last Funding Type
Series E
Last Funding Money Raised
$6.60M
Industries
Architecture,Health Care,Manufacturing,Medical Device
Founded date
Jan 1, 1997
Number Of Employee
51 - 100
Operating Status
Active

Vascular Architects, Inc. designs, develops, manufactures and markets devices used in the treatment of vascular stenoses, occlusions and non-vascular obstructions. A key area of emphasis is the treatment of peripheral vascular disease, which manifests itself as a reduction or loss of blood flow due to the narrowing or closing of arteries.

Vascular Architects was founded in October 1997 by Thomas J. Fogarty, M.D. Dr Fogarty is an internationally renowned surgeon, professor, inventor and entrepreneur who has founded or cofounded more than 25 start-up companies that develop innovative medical devices. He has authored or coauthored over 150 professional articles, is a member of 29 professional societies, and is an inventor on more than 65 U.S. patents.

Their founder and management team form a highly experienced group of technical, clinical and business personnel. Key opinion leaders in the interventional and vascular surgery communities have been recruited to serve on the Vascular Architects' Scientific Advisory Board.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$22.60M
Vascular Architects has raised a total of $22.60M in funding over 2 rounds. Their latest funding was raised on Sep 2, 2004 from a Series E round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 2, 2004 Series E $6.60M 2 Detail
Jan 6, 2003 Series D $16M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Vascular Architects is funded by 2 investors. Medtronic and ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Medtronic Series E
ARCH Venture Partners Series E